Grow Your Practice of Precision Oncology with Confidence 

Introducing Trapelo's Precision Medicine Advancement Program

The explosion in the number of genetic markers and available tests make it extremely challenging for all oncologists in your practice to cognitively keep up and consistently apply the highest standard of care. Many oncologists need decision support in real time to know:

  • Which molecular test(s) to order

  • Which labs and panels to use 

  • How to best interpret the results

  • Whether a test will be reimbursed


Trapelo is the first, precision diagnostic technology to help answers those questions and our new Precision Medicine Advancement Program enables practices to quickly and cost effectively begin using it.


This limited-time program is designed to help you deliver the highest standards in precision medicine for all doctors and for all patients.


Learn more.

Enables you to:

  • Ensure every oncologist across your network is consistent in their use of precision medicine

  • Streamline complex processes of molecular test ordering, lab selection, results interpretation and treatment selection

  • Eliminate traditional prior authorization, speeding care when time matters most

Choose the tier that’s right for your organization:


Introductory Subscription*

Sign up within 30 days, and start using Trapelo’s complete lab order management system right away to help oncologists order the right tests from any molecular lab in our wide network. Practices must submit at least 10 tests per month. Test results are presented in PDF/paper form just like they are today.


Configurable Subscription

We will configure the system to meet your practice preferences, and you will receive decision support, the ability to customize for your preferred labs, and access to Trapelo’s digital dashboard that enables everyone in the practice to access actionable, enhanced reporting.


Enterprise Subscription

Enjoy full access to Trapelo's tools and insights – integrated with your EMR and payer preferences to obviate traditional prior authorization.


*This offer is only available for a short time, so contact us today to see the different ways your practice can get started.

"The stakes have never been higher. Implementing precision medicine is no longer just a possibility, it is practically imperative. Cancer patients can’t wait.”                                    – Dr. Michael Caligiuri, president City of Hope National Medical Center

Dr. Michael Caligiuri, president of City of Hope national medical center, discusses the value of precision diagnostic technology
Dr. Michael Caligiuri, president of City of Hope national medical center, discusses the value of precision diagnostic technology

What was recently impossible for busy practices is practically imperative.

"Precision medicine is helping, at best, only a few percent of the nearly 2 million people who are diagnosed with cancer in the U.S. each year, and the fraction is much smaller among the 17 million cancer patients worldwide."   Source: Newsweek Magazine on closing the Precision Medicine gap

“Oncologists incorrectly matched the molecular alteration to the targeted therapy … in up to 69% [of cases]. This reflects a large knowledge gap among community Oncologists with regards to the correct application of MP [molecular profiling] to currently FDA-approved targeted therapies.”


Source: Bhavana Singh, MD, MSc, MedStar Georgetown University Hospital, ASCO 2019 abstract

Learn more about The Precision Medicine Advancement Program

and how it can complement your existing precision medicine initiatives

PHONE  617.250.7572

FAX  888.972.5991

EMAIL info@interventioninsights.com

800 District Ave, Suite 310
Burlington, MA 01803

Google Map »


Copyright 2019 Intervention Insights. All rights reserved. Privacy Policy